Coherus Oncology Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.54

-0.04 (-7.55%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 83%

Hold 2 17%

Sell 0 0%

Price Target

Analyst Price Target +6,622.4% upside

Low Target $24.75

Average Target $36.20

High Target $54.95

Current Price $0.54

Current
$0.54

Target
$36.20

$24.75 $36.20 avg $54.95

Scenario Analysis

Bear Case

$24.75

4,496.1%

Low target

Base Case

$36.20

+6,622.4%

Avg target

Bull Case

$54.95

+10,104.3%

High target

Risk/Reward

2.2x

Favorable

Price in Context

52-Week High

$2.62

-79.4% from high

52-Week Low

$0.73

+-26.4% from low

Target vs 52W High

$36.20

+1,283.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	-12.5%
AMGN Amgen Inc	Hold	42	43%	$190.87	-59.0%
GILD Gilead Sciences Inc	Strong Buy	36	83%	$362.68	+115.4%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-18.5%
MRNA Moderna Inc	Hold	31	32%	$149.45	-35.4%
REGN Regeneron Pharmaceuticals	Buy	36	72%	$76.80	-91.9%
NTRA Natera Inc	Strong Buy	31	90%	$142.91	-55.7%
RVMD Revolution Medicines Inc	Strong Buy	31	94%	$114.11	-35.3%